Capsugel
Pharma-giant Pfizer finally announced what we'd all be waiting for - the divestiture of Capsugel.
The hard capsule manufacturer will change hands for a whopping $2.375 billion in cash to an affiliate of Kohlberg Kravis Roberts & Co L.P. (KKR).
“The transaction is an endorsement of Capsugel’s consistent success to date and its potential for future growth with KKR, a firm with deep industry expertise and a long history of partnering with market-leading businesses to take them to the next level,” said Guido Driesen, current president and general manager of Capsugel who will retain leadership upon the completion of the transaction.